chitosan has been researched along with leflunomide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Boraie, N; Helmy, MW; Nafee, N; Zewail, M | 2 |
Asaad, GF; El-Dakroury, WA; El-Gizawy, SA; Shabana, ME; Zewail, MB | 1 |
3 other study(ies) available for chitosan and leflunomide
Article | Year |
---|---|
Coated nanostructured lipid carriers targeting the joints - An effective and safe approach for the oral management of rheumatoid arthritis.
Topics: Administration, Oral; Animals; Arthritis, Rheumatoid; Chitosan; Chondroitin Sulfates; Drug Carriers; Drug Liberation; Immunosuppressive Agents; Joints; Leflunomide; Lipids; Male; Nanostructures; Rats, Sprague-Dawley | 2019 |
Synergistic and receptor-mediated targeting of arthritic joints via intra-articular injectable smart hydrogels containing leflunomide-loaded lipid nanocarriers.
Topics: Animals; Arthritis, Rheumatoid; Chitosan; Hyaluronic Acid; Hydrogels; Leflunomide; Rats | 2021 |
Chitosan coated clove oil-based nanoemulsion: An attractive option for oral delivery of leflunomide in rheumatoid arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Chitosan; Clove Oil; Drug-Related Side Effects and Adverse Reactions; Leflunomide; Methotrexate; Rats; Surface-Active Agents; Tumor Necrosis Factor-alpha | 2023 |